Jose Ramon studies the potential of various substances and techniques to improve treatment outcomes for patients with cancer and other diseases. Specifically, he explores the effects of cannabis compounds on bladder cancer, the enhancement of immune responses through combined cancer treatments, and the development of novel drugs that minimize side effects while effectively targeting cancer cells. Additionally, he has investigated methods for delivering essential genetic materials into human cells to enhance therapies and treatments for genetic disorders, paving the way for advancements in gene therapy and personalized medicine.
Key findings
In a study on bladder cancer, specific cannabis strains reduced cancer cell growth significantly, with the PARIS strain showing a 21.58 microgram/milliliter effectiveness, and DQ and sCBD at 17.99 micrograms/milliliter.
NK-A 17E-233I, a new drug targeting the DHODH enzyme, effectively killed cancer cells while preserving normal cell functions, demonstrating a significant improvement over current treatments.
In a trial for advanced solid tumors using the drug JNJ-78306358, two patients experienced stable disease for over 40 weeks, suggesting promising durability in a challenging patient group.
The method of photoporation for loading extracellular vesicles achieved successful molecule incorporation in up to 53% of the vesicles, indicating a major advancement in drug delivery techniques.
The acute-to-chronic glycemic ratio was found to increase the risk of severe COVID-19 complications by over 3.9 times in diabetic patients, informing better management strategies.
Frequently asked questions
Does Dr. Ramon study cancer?
Yes, he focuses on various aspects of cancer treatment, including the effects of cannabis strains and developing new drugs that target cancer growth effectively.
What treatments has Dr. Ramon researched for bladder cancer?
He has researched the anti-cancer effects of specific cannabis strains, showing promising results in reducing cancer cell growth.
Is Dr. Ramon's work relevant to patients with rare diseases?
Yes, he has identified potential treatments for mitochondrial diseases and studied genetic mutations that contribute to such conditions.
How does Dr. Ramon improve drug delivery methods?
He has developed new techniques, such as photoporation, to enhance the incorporation of therapeutic molecules into cells, significantly improving treatment efficacy.
Can Dr. Ramon's research help with COVID-19 management?
Yes, his findings on the glycemic ratio in diabetic patients can help healthcare providers identify those at greater risk of severe complications from COVID-19.
Publications in plain English
Assessing the utility of statistical downscaling for subseasonal temperature forecasts.
2026
Scientific reports
Duzenli E, Ramon J, Torralba V, Pickard S, Muñoz ÁG +1 more
Plain English This study focused on improving temperature forecasts to help manage heat risks better, especially for events like the Paris 2024 Olympics. Researchers tested 27 different statistical methods to see how well they could refine weekly temperature predictions from a rough, large-scale forecast system. They found that while most methods improved accuracy at a local level, choosing the right approach was crucial; some techniques worked very well, while others made predictions worse.
Who this helps: This benefits event organizers, athletes, and public health officials who need accurate weather information to prepare for extreme heat during large events.
Gentle and efficient engineering of primary human NK cells by photoporation with polydopamine nanosensitizers.
2025
Journal of controlled release : official journal of the Controlled Release Society
Hinnekens C, Ramon J, Birben M, Germeraad WTV, Harizaj A +5 more
Plain English Researchers studied a new method called photoporation using polydopamine nanosensitizers to improve the engineering of natural killer (NK) cells, which play a role in fighting infections and cancer. They found that this method successfully transferred specific genetic materials into NK cells without affecting their ability to function or grow. This is significant because it offers a gentle and effective way to modify NK cells for therapies, making it easier to develop treatments for various diseases.
Who this helps: This helps patients who could benefit from improved cancer therapies.
Immunogenic cell death as interplay between physical anticancer modalities and immunotherapy.
2025
Journal of controlled release : official journal of the Controlled Release Society
Engelen Y, Demuynck R, Ramon J, Breckpot K, De Smedt SC +4 more
Plain English This research focused on how certain cancer treatments that use physical methods, like radiotherapy and focused ultrasound, can help stimulate the body's immune system to fight cancer more effectively. The study found that these methods can trigger a process called immunogenic cell death, which enhances the immune response without causing extensive damage to surrounding tissues. This is important because it means these treatments could lead to better patient outcomes while minimizing side effects.
Who this helps: This benefits cancer patients looking for more effective and targeted treatment options.
Pre-formation loading of extracellular vesicles with exogenous molecules using photoporation.
2025
Journal of nanobiotechnology
Ramon J, Pinheiro C, Vandendriessche C, Lozano-Andrés E, De Keersmaecker H +11 more
Plain English This study explored a new method for loading tiny particles called extracellular vesicles (EVs) with specific substances before they are formed. The researchers used a technique called photoporation, which allows for the delivery of molecules into cells without harming them. They successfully loaded up to 53% of the EVs with targeted molecules and around 12% with non-targeted ones, indicating this method could make it easier to incorporate useful materials into EVs for future therapies.
Who this helps: This benefits researchers and companies working on advanced drug delivery systems.
NK-A 17E-233I: a novel competitive inhibitor of human dihydroorotate dehydrogenase (DHODH) for cancer therapy.
2025
Journal of experimental & clinical cancer research : CR
Anwar MM, Meseguer S, García-Rodríguez N, Krupinska E, Sele C +11 more
Plain English Researchers studied a new drug called NK-A 17E-233I, which targets an enzyme linked to cancer growth called DHODH. They found that this drug effectively kills cancer cells and damages their DNA while preserving healthy cell functions, unlike existing treatments. This is important because it could lead to more effective cancer therapies with fewer side effects.
Who this helps: This benefits cancer patients looking for better treatment options.
Targeting bladder cancer: Potent anti-cancer effects of cannabichromene and delta-9-tetrahydrocannabinol-richstrains.
2025
Asian journal of urology
Anis O, Bar V, Zundelevich A, Anil SM, Shav-Tal Y +9 more
Plain English This study looked at the effects of certain cannabis strains on bladder cancer cells. The researchers found that the strains PARIS, Dairy Queen (DQ), and super cannabidiol (sCBD) were particularly effective, with PARIS reducing cancer cell growth at a concentration of about 21.58 micrograms per milliliter, while DQ and sCBD did so at around 17.99 micrograms per milliliter. These findings are important because they highlight the potential of these cannabis compounds in treating bladder cancer.
Who this helps: This helps patients with bladder cancer looking for new treatment options.
Laser-induced vapor nanobubbles for B16-F10 melanoma cell killing and intracellular delivery of chemotherapeutics.
2024
Journal of controlled release : official journal of the Controlled Release Society
Ramon J, Engelen Y, De Keersmaecker H, Goemaere I, Punj D +9 more
Plain English This study investigated a new method for killing melanoma cells using lasers. The researchers found that using pulsed lasers created tiny vapor bubbles around melanoma cells that led to significant cell damage, with nearly all cells showing signs of death just four hours after treatment. This approach not only kills cancer cells efficiently but also helps deliver chemotherapy inside the cells, enhancing the overall effectiveness of treatment.
Who this helps: This benefits melanoma patients by offering a more effective treatment option with potentially fewer side effects.
Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors.
2024
Cancer immunology, immunotherapy : CII
Geva R, Vieito M, Ramon J, Perets R, Pedregal M +16 more
Plain English This study looked at a new drug called JNJ-78306358, which targets certain cancer cells to help treat advanced tumors in 39 patients. While most patients experienced side effects, like flu-like symptoms in about half, there were no severe cases, and two patients maintained stable disease for more than 40 weeks. This research is important because it explores a new treatment option for patients with hard-to-treat cancers that express HLA-G, though the side effects may limit how much the dose can increase for effective treatment.
Who this helps: This helps patients with advanced solid tumors like colorectal, ovarian, and renal cancers.
Guanylate Kinase 1 Deficiency: A Novel and Potentially Treatable Mitochondrial DNA Depletion/Deletions Disease.
2024
Annals of neurology
Hidalgo-Gutierrez A, Shintaku J, Ramon J, Barriocanal-Casado E, Pesini A +23 more
Plain English This study looked at four patients who have a rare mitochondrial disease but did not have known genetic causes. The researchers found that all four patients had a specific genetic mutation in the GUK1 gene, which is important for mitochondrial function. This mutation led to muscle weakness, eye problems, and issues with the liver and immune cells. Importantly, treating patient cells with certain drugs showed promise in improving the mitochondrial defects caused by this mutation.
Who this helps: This research benefits patients with GUK1 deficiency and similar mitochondrial diseases by identifying a potential treatment option.
Complete Genome Sequences of Phages EarickHC, Figueroism, FinalFrontier, SBlackberry, Skylord, and Slay isolated using.
2024
microPublication biology
Barruga B, Benitez S, Bouit E, Bouit T, Cagang E +44 more
Plain English This study looks at six types of viruses called phages, which were found in soil in Southern California. The researchers discovered that these phages can injure or kill bacteria, have various lengths of genetic material, and contain between 58 and 91 genes that tell them how to function. Understanding these phages is important because they could be used to treat bacterial infections, especially those that are resistant to antibiotics.
Who this helps: This helps patients with hard-to-treat bacterial infections.
Automated detection of toxicophores and prediction of mutagenicity using PMCSFG algorithm.
2023
Molecular informatics
Schietgat L, Cuissart B, De Grave K, Efthymiadis K, Bureau R +3 more
Plain English This study looked at a new method for identifying harmful chemical structures (toxicophores) and predicting whether these chemicals might cause mutations (mutagenicity) by using a special algorithm called PMCSFG. The researchers found that their method, which focuses on key structural similarities, outperformed 12 traditional ways of analyzing chemicals, showing better predictive accuracy for mutation risks. This is important because it means scientists can more reliably identify dangerous chemicals, improving safety assessments.
Who this helps: This benefits researchers and regulators working to ensure chemical safety.
Acute-to-Chronic Glycemic Ratio as a Predictor of COVID-19 Severity and Mortality.
2022
Diabetes care
Ramon J, Llauradó G, Güerri R, Climent E, Ballesta S +8 more
Plain English This study looked at how the ratio of a patient's short-term to long-term blood sugar levels can predict how severe their COVID-19 illness will be and whether they will survive. Researchers found that among 91 hospitalized patients with type 2 diabetes, a higher acute-to-chronic glycemic ratio was linked to worse outcomes, with a particular danger for those in the highest group (over 3.9 times more likely to face serious complications compared to those with better ratios). Understanding this connection can help doctors identify which diabetes patients are at greater risk for severe COVID-19.
Who this helps: This helps patients with type 2 diabetes and their healthcare providers in managing COVID-19 risks.
Light triggered nanoscale biolistics for efficient intracellular delivery of functional macromolecules in mammalian cells.
2022
Nature communications
Fraire JC, Shaabani E, Sharifiaghdam M, Rombaut M, Hinnekens C +14 more
Plain English This study explored a new method for delivering important genetic materials into mammalian cells using tiny particles called nanobombs, which are activated by laser light. The researchers showed that this method is much more effective than traditional techniques, achieving a 5.5 to 7.6 times higher success rate in getting these materials into the cells. This advancement is significant because it could improve the way we introduce therapies or genetic modifications into cells, making treatments more efficient and effective.
Who this helps: This benefits patients who need gene therapy or other genetic treatments.
Palaeogenomic analysis of black rat (Rattus rattus) reveals multiple European introductions associated with human economic history.
2022
Nature communications
Yu H, Jamieson A, Hulme-Beaman A, Conroy CJ, Knight B +54 more
Plain English Researchers studied how the black rat, a rodent closely linked to human activity, spread across Europe throughout history. They found that black rats were brought to Europe from Southwest Asia, with significant changes in their population occurring between the 6th and 10th centuries. This shift in numbers likely relates to historical events like the fall of the Roman Empire and climate changes, which is important for understanding how human actions affect rodent populations and ecosystems.
Who this helps: This information benefits ecologists and historians studying the impact of human activities on wildlife.
A Reference Architecture for Cloud-Edge Meta-Operating Systems Enabling Cross-Domain, Data-Intensive, ML-Assisted Applications: Architectural Overview and Key Concepts.
Plain English This study introduces a new system design called RAMOS that improves how data-intensive applications operate between the cloud (where data is stored) and edge devices (like sensors and IoT gadgets). The authors found that RAMOS can support various devices and networks in a secure way, handling large amounts of data more effectively than current systems. This matters because it can enhance smart applications, improve data privacy, and help reduce environmental impact in the future.
Who this helps: This benefits developers of smart technology, businesses using IoT devices, and society as a whole by promoting better data management and environmental practices.
Histology results of systematic prostate biopsies by in-bore magnetic resonance imaging vs. transrectal ultrasound.
2021
Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Lazarovich A, Raviv G, Laitman Y, Portnoy O, Raz O +3 more
Plain English This study compared two methods of performing prostate biopsies: one guided by magnetic resonance imaging (MRI) and the other by transrectal ultrasound (TRUS). Of the 128 patients analyzed, both methods identified similar rates of prostate cancer, but the TRUS method showed more high-risk cases, with 22.4% of TRUS patients having high-risk disease compared to only 4.9% of MRI patients. This finding is important because it indicates that while both methods can detect cancer, TRUS may identify more severe cases.
Who this helps: This helps doctors decide which biopsy method to use for their patients.
Cannabis-Derived Compounds Cannabichromene and Δ9-Tetrahydrocannabinol Interact and Exhibit Cytotoxic Activity against Urothelial Cell Carcinoma Correlated with Inhibition of Cell Migration and Cytoskeleton Organization.
2021
Molecules (Basel, Switzerland)
Anis O, Vinayaka AC, Shalev N, Namdar D, Nadarajan S +6 more
Plain English This study looked at compounds from cannabis, specifically cannabichromene (CBC) and Δ9-tetrahydrocannabinol (THC), to see how they affect bladder cancer cells. The researchers found that when combined, CBC and THC killed these cancer cells and prevented them from moving and spreading, indicating that they work well together. This is important because it highlights potential new treatments for bladder cancer using natural cannabis compounds.
Who this helps: This benefits patients with bladder cancer looking for new treatment options.
A comparative cost analysis between two quick diagnosis units of different levels of complexity.
2021
Journal of comparative effectiveness research
Bosch X, Montori E, Merino-Peñas MJ, Compta Y, Ladino A +2 more
Plain English This study looked at the costs of two quick diagnosis units in hospitals—one more advanced (tertiary) and one less complex (secondary). They analyzed 407 patients and found that it cost an average of €577.50 for each patient in the tertiary unit compared to €394.70 in the secondary unit. The higher costs in the tertiary unit were mainly due to more visits, more staff, and more complex cases.
Who this helps: This helps hospital administrators and health policymakers understand where resources are used within healthcare facilities.
Associations between T cell infiltration, T cell receptor clonality, histology and recurrence in renal cell carcinoma.
2021
Clinical and experimental immunology
Gadot M, Gal M, Dobosz P, Dotan Z, Ramon J +4 more
Plain English This study looked at kidney cancer, specifically how immune cells called T cells are present in different types of tumors and how this relates to whether the cancer comes back after treatment. Researchers found that in patients whose cancer did not return, the average amount of T cells in the tumors was 2.5 times higher, and these T cells were 4.3 times more diverse compared to those whose cancer did recur. This matters because it shows that having more T cells could be linked to a lower chance of cancer returning, helping to understand how to better treat and monitor kidney cancer patients.
Who this helps: This helps patients and doctors by providing insights that could lead to improved treatment strategies for kidney cancer.
The urologist's learning curve of "in-bore" magnetic resonance-guided prostate biopsy.
2021
BMC urology
Rosenzweig B, Drori T, Raz O, Goldinger G, Shlomai G +5 more
Plain English This study examined how well urologists can learn to perform a specific type of prostate biopsy guided by MRI, known as in-bore MRI-guided prostate biopsy (IB-MRGpB). Researchers reviewed data from 110 procedures and found that while the biopsy duration average was about 28 minutes, the rate of detecting clinically significant prostate cancer was consistent, at around 19% for lower risk lesions and increasing to 69% for higher risk lesions, regardless of the doctor's experience. This means that even less experienced urologists can effectively detect serious prostate cancers using this method without needing much time to get proficient.
Who this helps: Patients who need accurate prostate cancer diagnosis and treatment.
Plasma membrane perforation by GSDME during apoptosis-driven secondary necrosis.
2021
Cellular and molecular life sciences : CMLS
De Schutter E, Ramon J, Pfeuty B, De Tender C, Stremersch S +6 more
Plain English This study looked at how a protein called Gasdermin E (GSDME) affects cell breakdown during a specific type of cell death known as secondary necrosis. The researchers found that GSDME helps speed up how quickly cells break apart and allows certain small molecules to enter and exit the cell, but the process depends on the size of these molecules. This is important because understanding how GSDME works could lead to better treatments for diseases where cell death plays a significant role, like cancer.
Who this helps: Patients dealing with cancer and related therapies.
Selective Arterial Embolization for Large or Symptomatic Renal Angiomyolipoma: 10 Years of Follow-up.
2020
Urology
Anis O, Rimon U, Ramon J, Khaitovich B, Zilberman DE +2 more
Plain English This study looked at how well selective arterial embolization (SAE) works as a first treatment for large or symptomatic renal angiomyolipoma (AML) over ten years. Out of 71 patients, 19% experienced serious health issues related to their AML, and 41% needed a second treatment within about 2 years. Patients saw a 27% decrease in tumor size over ten years, and all patients had good kidney function without needing dialysis.
Who this helps: This benefits patients with renal angiomyolipoma, especially those with large or symptomatic tumors.
Tandem Ureteral Stents for Malignant Ureteral Obstruction.
2020
Journal of endourology
Haifler M, Shvero A, Zilberman D, Ramon J, Winkler H +2 more
Plain English This study looked at how well tandem ureteral stents (TUS) work for patients with malignant ureteral obstruction, a serious problem caused by cancer. Out of 81 patients analyzed, 72.9% were successful with TUS and did not need extra drainage from a nephrostomy tube, but about 22% faced complications. The findings showed that TUS can effectively relieve kidney issues without needing external drainage, although patients with metastasis and those who had prior nephrostomy were more likely to experience stent failure.
Who this helps: This benefits cancer patients suffering from ureteral obstruction and their doctors managing their care.
[THE EFFICACY OF ENDOSCOPIC DUAL LASER TREATMENT FOR LOW GRADE UPPER TRACT UROTHELIAL CARCINOMA].
2020
Harefuah
Shvero A, Zilberman DE, Laufer M, Dotan ZA, Ramon J +2 more
Plain English This study examined a new treatment for low-grade upper tract urothelial carcinoma (a type of bladder cancer) using a special laser system. Out of 38 patients treated with this method, there were no serious complications during the procedure, although 73% experienced a return of their cancer after an average follow-up of about 22 months. This treatment is important because it allows patients to preserve their kidneys and avoid major surgery while still showing promising results in the short term.
Who this helps: This benefits cancer patients looking for less invasive treatment options.
Management of Pancreatic Injuries Following Nephrectomy.
2020
The Israel Medical Association journal : IMAJ
Horesh N, Abu-Ghanem Y, Erlich T, Rosin D, Gutman M +3 more
Plain English This study looked at how often pancreatic injuries happen during kidney removal surgery (nephrectomy) and their consequences. Out of 1,674 patients, only four (0.2%) had injuries to the pancreas, which were not detected during surgery. Although these injuries are rare, they can lead to serious complications, with patients staying in the hospital for an average of 65 days.
Who this helps: This helps doctors and surgeons understand the risks associated with nephrectomy and improve patient care.
Effects of "real life" prostate MRI inter-observer variability on total needle samples and indication for biopsy.
2020
Urologic oncology
Rosenzweig B, Laitman Y, Zilberman DE, Raz O, Ramon J +2 more
Plain English This study looked at how different doctors interpret prostate MRI scans and how this affects decisions about taking biopsies. They found that after reviewing the scans, one doctor changed the assessment for more than half of the lesions, leading to a delay in biopsies for 27% of the patients and avoiding over 136 needle samples. This is important because it shows that inconsistencies in MRI readings can significantly impact patient care and reduce unnecessary procedures.
Who this helps: Patients undergoing prostate evaluations.
Outreach and Influence of Surgical Societies' Recommendations on Minimally Invasive Surgery During the COVID-19 Pandemic-An Anonymized International Urologic Expert Inquiry.
2020
Urology
Boehm K, Thomas A, Bex A, Black PC, Coburn M +9 more
Plain English This study looked at how well surgical societies’ recommendations for minimally invasive surgery (MIS) were followed during the COVID-19 pandemic. Researchers surveyed 62 hospitals worldwide and found that those in countries hit hardest by the virus were more likely to adapt their practices according to the guidelines. Specifically, hospitals in high-burden countries adjusted their procedures more frequently, especially regarding testing patients and handling surgical materials. This information is important because it highlights the effectiveness of timely guidelines during a health crisis and suggests that quick sharing of recommendations can improve surgical practices in future emergencies.
Who this helps: This benefits doctors and healthcare institutions involved in surgery.
Quick diagnosis units: predictors of time to diagnosis and costs.
2020
Medicine
Montori-Palacín E, Ramon J, Compta Y, Insa M, Prieto-González S +5 more
Plain English This study looked at quick diagnosis units (QDUs) in a hospital in Barcelona to understand what affects the costs and time it takes to get a diagnosis. Researchers found that patients with conditions like cancer or organic disorders took longer and cost more to diagnose, with an average diagnosis time of 12 days. Specifically, imaging was a major contributor to costs, making it important to streamline the process in order to enhance efficiency and keep expenses down.
Who this helps: This benefits patients by potentially improving the speed and cost of their diagnosis.
Trends in urologic oncology clinical practice and medical education under COVID-19 pandemic: An international survey of senior clinical and academic urologists.
2020
Urologic oncology
Rosenzweig B, Bex A, Dotan ZA, Frydenberg M, Klotz L +4 more
Plain English This study looked at how urologic cancer doctors around the world adapted their practices during the COVID-19 pandemic. Out of 100 surveyed surgeons, 63 responded, revealing that while new patient visits largely continued, 83.3% postponed follow-ups for low-risk kidney issues, and 76.2% delayed major surgeries like prostate removal. These findings highlight significant delays in care, particularly in Europe, and emphasize the need for better planning in future healthcare crises.
Who this helps: Patients with urologic cancers and their healthcare providers.
Intraoperative but not postoperative blood transfusion adversely affect cancer recurrence and survival following nephrectomy for renal cell carcinoma.
2019
Scientific reports
Abu-Ghanem Y, Dotan Z, Zilberman DE, Kaver I, Ramon J
Plain English This study looked at how blood transfusions during and after surgery affect the outcomes for patients with kidney cancer who had surgery to remove tumors. Researchers found that transfusions given during surgery were linked to higher chances of cancer returning and increased mortality rates. Specifically, patients who received these transfusions were 2.4 times more likely to see their cancer return and 3.5 times more likely to die from it compared to those who did not receive transfusions during surgery.
Who this helps: This information benefits kidney cancer patients and their doctors by providing important insights into care during surgery.
Closed-loop cycles of experiment design, execution, and learning accelerate systems biology model development in yeast.
2019
Proceedings of the National Academy of Sciences of the United States of America
Coutant A, Roper K, Trejo-Banos D, Bouthinon D, Carpenter M +8 more
Plain English This research focused on improving complex biological models in yeast, particularly the diauxic shift, which is a process that yeast undergoes when switching energy sources. The scientists successfully enhanced their model through three rounds of experimentation, leading to the discovery of 92 new genes and 1,048 new interactions related to this process. This is important because understanding these biological mechanisms can help advance research in areas like cancer, the immune system, and aging.
Who this helps: Patients and doctors working in fields related to cancer and aging.
Impact of perioperative blood transfusions on clinical outcomes in patients undergoing surgery for major urologic malignancies.
2019
Therapeutic advances in urology
Abu-Ghanem Y, Ramon J
Plain English This study looked at how getting blood transfusions during surgery affects the health outcomes of patients with major urologic cancers, like those in the prostate and bladder. The researchers found that up to 62% of patients undergoing these types of surgeries receive blood transfusions, and previous studies have linked transfusions to poorer survival rates in cancer patients. Understanding this relationship is important because it can lead to better guidelines for when blood transfusions should be given during these surgeries.
Who this helps: This helps patients undergoing surgery for urologic cancers and their doctors.
Ureteric stent versus percutaneous nephrostomy for acute ureteral obstruction - clinical outcome and quality of life: a bi-center prospective study.
2019
BMC urology
Shoshany O, Erlich T, Golan S, Kleinmann N, Baniel J +6 more
Plain English The study compared two methods for relieving acute kidney blockage: ureteric stents (DJS) and nephrostomy tubes (PCN). It involved 75 patients and found that while both treatments had similar overall recovery rates, patients with nephrostomy tubes reported better improvements in their quality of life over time. Specifically, DJS patients experienced more ongoing urinary discomfort, while PCN patients had worse mobility issues initially, but their symptoms improved, leading to a better quality of life score in the long run.
Who this helps: This research benefits patients with acute ureteral obstruction by guiding the choice of treatment based on quality of life outcomes.
Design and 3D-printing of titanium bone implants: brief review of approach and clinical cases.
2018
Biomedical engineering letters
Popov VV, Muller-Kamskii G, Kovalevsky A, Dzhenzhera G, Strokin E +2 more
Plain English This research paper looks at the process of creating customized titanium bone implants using 3D printing technology. The study highlights how 3D-printed implants can help patients recover better, especially when they're the only option besides amputation. Although there are still challenges in this field, the use of patient-specific implants offers a fast solution for complex surgeries.
Who this helps: Patients who need specialized bone implants.
Zohar A Dotan Dorit E Zilberman Kevin Braeckmans Barak Rosenzweig Orith Portnoy Yasmin Abu-Ghanem Omer Anis Zohar Dotan Juan C Fraire Stephan Stremersch
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.